Filing Details
- Accession Number:
- 0001209191-15-002623
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-06 20:15:07
- Reporting Period:
- 2015-01-04
- Filing Date:
- 2015-01-06
- Accepted Time:
- 2015-01-06 20:15:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1114220 | Keryx Biopharmaceuticals Inc | KERX | Pharmaceutical Preparations (2834) | 134087132 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1251213 | Ron Bentsur | C/O Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue New York NY 10022 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-01-04 | 67,375 | $0.00 | 784,375 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2015-01-05 | 5,574 | $13.79 | 778,801 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2015-01-04 | 134,750 | $0.00 | 134,750 | $14.34 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 134,750 | 2016-01-04 | 2025-01-04 | No | 4 | A | Direct |
Footnotes
- The 67,375 shares are restricted common stock, with one-third of the 67,375 shares vesting on January 4, 2016, and one-twelfth vesting on each of April 4, 2016, July 4, 2016, October 4, 2016, January 4, 2017, April 4, 2017, July 4, 2017, October 4, 2017, and January 4, 2018.
- Includes 93,445 shares of restricted stock.
- Sale of a total of 5,574 shares of common stock was made in order to satisfy Mr. Bentsur's income tax withholding obligation upon the vesting of 13,705 shares of restricted stock on January 2, 2015. Mr. Bentsur had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- The options vest according to the following schedule: one-third of the 134,750 options will vest on January 4, 2016, and one-twelfth will vest on each of April 4, 2016, July 4, 2016, October 4, 2016, January 4, 2017, April 4, 2017, July 4, 2017, October 4, 2017, and January 4, 2018.
Billionaire Hedge Funds
